Trials / Completed
CompletedNCT03471949
Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test
Evaluation of the Profile of Blood Glucose Using Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Vastra Gotaland Region · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to obtain reference values of CGM in healthy individuals using the Dexcom G4 sensor and evaluate whether reported low glucose values by the Dexcom G4 sensor are really low when confirmed by capillary testing.
Detailed description
Evaluation of the profile of blood glucose using Dexcom G4 in a population with normal oral glucose tolerance test. The investigators have used information from a previous study of 60 participants using Dexcom G4, CGM system. A non-randomized, days 1-7 blinded and days 8-14 non-blinded CGM trial, the study was performed to evaluate the profile of blood glucose using CGM in the population with normal oral glucose tolerance test (OGTT). All enrolled subjects with at least three time-points with evaluable values from CGM system and the reference capillary value obtained from HemoCue during the whole study period were included in the Intent-to-Treat (ITT) population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CGM in a population with normal OGTT | The population with normal OGTT will use CGM and document their values as well as be documenting a capillary blood glucose value |
Timeline
- Start date
- 2016-10-24
- Primary completion
- 2018-12-11
- Completion
- 2018-12-11
- First posted
- 2018-03-21
- Last updated
- 2019-04-25
Source: ClinicalTrials.gov record NCT03471949. Inclusion in this directory is not an endorsement.